CORRELATION BETWEEN COVID-19 SEVERITY AND NONINVASIVE ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD)

被引：0
|
作者：
Tungtrongchitr, Nuttapat
Srivanitchapoom, Nantaporn
Hirunpat, Pornrujee
Sungkanuparph, Somnuek
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
MAFLD; COVID-19; fibrosis; 8; score; 4; non-alcoholic fatty liver disease fibrosis score;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1509
引用
收藏
页码：S1394 / S1395
页数：2
相关论文
共 50 条
  • [21] Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
    Fouad, Yasser
    Alboraie, Mohamed
    Shiha, Gamal
    HEPATOLOGY INTERNATIONAL, 2024, 18 (SUPPL 2) : 827 - 833
  • [22] Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19
    Campos-Murguia, Alejandro
    Monserrat Roman-Calleja, Berenice
    Vicente Toledo-Coronado, Israel
    Alberto Gonzalez-Regueiro, Jose
    Adrian Solis-Ortega, Alberto
    Kusulas-Delint, Deyanira
    Cruz-Contreras, Mariana
    Cruz-Yedra, Nabila
    Javier Cubero, Francisco
    Alexandrowna Nevzorova, Yulia
    Fernando Martinez-Cabrera, Carlos
    Moreno-Guillen, Paulina
    Arturo Lozano-Cruz, Oscar
    Chapa-Ibarguengoitia, Monica
    Gulias-Herrero, Alfonso
    Alberto Aguilar-Salinas, Carlos
    Ruiz-Margain, Astrid
    Ulises Macias-Rodriguez, Ricardo
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (05) : 525 - 533
  • [23] Body Composition Analysis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
    Onishi, Saori
    Fukuda, Akira
    Matsui, Masahiro
    Ushiro, Kosuke
    Nishikawa, Tomohiro
    Asai, Akira
    Kim, Soo Ki
    Nishikawa, Hiroki
    NUTRIENTS, 2023, 15 (18)
  • [24] LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease
    Leow, Yong Wen
    Chan, Wah Loong
    Lai, Lee Lee
    Mustapha, Nik Raihan Nik
    Mahadeva, Sanjiv
    Quiambao, Ronald
    Munteanu, Mona
    Chan, Wah Kheong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (10) : 2182 - 2189
  • [25] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
  • [26] Risk of Severe COVID-19 Increased by Metabolic Dysfunction-associated Fatty Liver Disease A Meta-analysis
    Tao, Ziwen
    Li, Yueyue
    Cheng, Baoquan
    Zhou, Tao
    Gao, Yanjing
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (10) : 830 - 835
  • [27] Metabolic dysfunction-associated fatty liver disease indicates more hepatic fibrosis than nonalcoholic fatty liver disease
    Hong, Shan
    Hong, Zifan
    Hao, Yiwei
    Sun, Lei
    Wei, Hongshan
    MEDICINE, 2025, 104 (06) : e41455
  • [28] Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Hong Fan
    Lili Li
    Zhenqiu Liu
    Pengyan Zhang
    Sheng Wu
    Xinyu Han
    Xingdong Chen
    Chen Suo
    Liou Cao
    Tiejun Zhang
    BMC Gastroenterology, 23
  • [29] Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19
    Campos-Murguia, Alejandro
    Roman-Calleja, Berenice M.
    Gonzalez-Regueiro, Jose A.
    Hurtado-Diaz-de-Leon, Ivonne
    Solis-Ortega, Alberto Adrian
    Flores-Garcia, Nayelli C.
    Garcia-Juarez, Ignacio
    Ruiz-Margain, Astrid
    Macias-Rodriguez, Ricardo Ulises
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (33) : 5502 - 5519
  • [30] Identification of Hepatic Dendritic Cells in Liver Biopsies in Patients with Metabolic Dysfunction-Associated Fatty Liver Diseas (MAFLD) and Obesity
    Barranco-Fragoso, Beatriz
    Pal, Shreya C.
    Diaz-Orozco, Luis E.
    Dorantes-Heredia, Rita
    Qi, Xingshun
    Mendez-Sanchez, Nahum
    MEDICAL SCIENCE MONITOR, 2022, 28
12345